Medical Editor: John P. Cunha, DO, FACOEP
The recommended regimen of Azasite is 1 drop twice daily for the first two days and then 1 drop once daily for the next five days.
Azasite (azithromycin ophthalmic solution) is a semi-synthetic macrolide antibiotic used for the treatment of bacterial conjunctivitis. Common side effects of Azasite include eye irritation (stinging, burning), blurred vision, dry eyes, and stuffy nose. There are no adequate studies of Azasite in pregnant women and it is not known whether Azasite is excreted in breast milk. Only use Azasite in pregnant or nursing mothers when absolutely necessary.
Our Azasite Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing or swallowing; swelling of your face, lips, tongue, or throat.
Stop using azithromycin ophthalmic and call your doctor at once if you have:
- drainage or crusting of your eye;
- severe burning, stinging, itching, or other irritation after using the eye drops;
- feeling like something is in your eye;
- watery eyes, increased light sensitivity;
- eye pain, redness, or swelling;
- any signs of a new infection; or
- signs of a rare but serious reaction--fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
Common side effects may include:
- dry or itchy eyes;
- blurred vision;
- changes in your sense of taste;
- stuffy nose; or
- mild stinging, burning, or irritation of your eyes.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Azasite (Azithromycin Ophthalmic Solution)
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in one clinical trial of a drug cannot be directly compared with the rates in the clinical trials of the same or another drug and may not reflect the rates observed in practice.
The data described below reflect exposure to AzaSite in 698 patients. The population was between 1 and 87 years old with clinical signs and symptoms of bacterial conjunctivitis. The most frequently reported ocular adverse reaction reported in patients receiving AzaSite was eye irritation. This reaction occurred in approximately 1-2% of patients. Other adverse reactions associated with the use of AzaSite were reported in less than 1% of patients and included ocular reactions (blurred vision, burning, stinging and irritation upon instillation, contact dermatitis, corneal erosion, dry eye, eye pain, itching, ocular discharge, punctate keratitis, visual acuity reduction) and non-ocular reactions (dysgeusia, facial swelling, hives, nasal congestion, periocular swelling, rash, sinusitis, urticaria).
Read the entire FDA prescribing information for Azasite (Azithromycin Ophthalmic Solution)
© Azasite Patient Information is supplied by Cerner Multum, Inc. and Azasite Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.